pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of CYP3A4 inducers might lessen sufentanil ranges and efficacy, quite possibly precipitating withdrawal syndrome in patients that have created physical dependence to sufentanil. Discontin